Xenical (Orlistat) - Summary

XENICAL SUMMARY

XENICAL (orlistat) is a lipase inhibitor for obesity management that acts by inhibiting the absorption of dietary fats.

XENICAL is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. XENICAL is also indicated to reduce the risk for weight regain after prior weight loss. XENICAL is indicated for obese patients with an initial body mass index (BMI) >/=30 kg/m² or >/=27 kg/m² in the presence of other risk factors (eg, hypertension, diabetes, dyslipidemia).

XENICAL NEWS HIGHLIGHTS

Published Studies Related to Xenical (Orlistat)

Orlistat treatment of unconjugated hyperbilirubinemia in Crigler-Najjar disease: a randomized controlled trial. [2007.12]

Rapid response predicts binge eating and weight loss in binge eating disorder: Findings from a controlled trial of orlistat with guided self-help cognitive behavioral therapy. [2007.11]

Effect of orlistat on fecal fat, fecal biliary acids, and colonic cell proliferation in obese subjects. [2007.11]

Orlistat and sibutramine beyond weight loss. [2007.10.08]

Long-term persistence with orlistat and sibutramine in a population-based cohort. [2007.10]

more>>

Clinical Trials Related to Xenical (Orlistat)

Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder

Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)

Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases

Orlistat Treatment of Crigler-Najjar Disease

The Effect of Xenical on Weight and Risk Factors

more>>